D-0150-2020 Class II Terminated

Recalled by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center — West Columbia, SC

FDA drug recall D-0150-2020 was initiated by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center on Oct 9, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; bags have potential to leak The recall status is terminated (terminated Dec 1, 2020). Affected quantity: 162 bags.

Recall details

Product Type
Drugs
Report Date
Oct 30, 2019
Initiation Date
Oct 9, 2019
Termination Date
Dec 1, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
162 bags

Product description

Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25 g L-Arginine HCl; 25 g L-Lysine HCl, Single Dose Container, Rx Only Nephron 503B outsourcing facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-988-10

Reason for recall

Lack of Assurance of Sterility; bags have potential to leak

Distribution pattern

Nationwide.

Code information

Lots: AA9023A Exp. 10/24/2019; AA9023B Exp. 10/24/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0150-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0150-2020. Report a data issue: hello@regdatalab.com.